Reverse Mergers and SPACs: Are APOs the New Norm for Biotechs Going Public? 2020 was an unprecedented year for Special Purpose Acquisition Corps (SPACs), an alternative public offering (APO) financing vehicle for listing on a public stock exchange. Best Practices & Trends Finance Life Sciences Mergers & Acquisitions Webinars
Cybersecurity Best Practices for 2021 If cybersecurity is not on the top of your company's list of initiatives for 2021, then it should be, and even if it is, you may not be doing enough. Best Practices & Trends Security Webinars
Valuation of Your Early Drug Candidate In this whitepaper, author Linda Pullan reviews the different techniques, key variables, and characteristics of what makes a drug candidate more valuable to a partner. Life Sciences Series Valuation Whitepapers
Getting Ready for a Biopharma Partnering Deal This whitepaper provides actionable advice for Biotech business development leaders on how to get ready for a partnering deal. Best Practices & Trends BioPharma Licensing & Partnering Life Sciences Series Whitepapers
The Nuts & Bolts of Due Diligence in Biopharma Partnering This whitepaper focuses on best practices in due diligence with the goal of forming productive biopharma partnerships. Best Practices & Trends BioPharma Due Diligence Licensing & Partnering Life Sciences Series Whitepapers
What's Hot and What's Not in Oncology Licensing in 2020? In this whitepaper, Linda Pullan, PhD of Pullan Consulting and our panel of experts provided insights in oncology and immuno-oncology in 2020. Best Practices & Trends BioPharma Life Sciences Other Topics Series Whitepapers
How to Win at the Partnering Game In this white paper, Linda Pullan provides a review of the rules of the partnering game – whether it’s partnering from preclinical to late clinical development – to provide an understanding of what to expect in moving from introductions to negotiations of a license or acquisition and how to win with a clear strategy. Best Practices & Trends BioPharma Licensing & Partnering Life Sciences Series Whitepapers
Paradigm Changing Technologies in Oncology This webinar part of a continuing series of forward-looking sessions as Linda Pullan and Jeff Bockman lead a virtual panel of Oncology luminaries with diverse perspectives including VC, Pharma, Biotech, and Strategic Consulting. BioPharma Life Sciences Other Topics Webinars
Pivot to Cash: Bankruptcy & Restructuring in a Distressed Environment Alvarez and Marsal, a global professional services firm, explore the current trends in turnarounds and restructuring and what it means for distressed companies in today’s environment. Best Practices & Trends BioPharma Finance Other Topics Webinars
Microbiome: Hope or Hype? This webinar discusses how will microbiome impact human therapeutics, who's driving it, and why. Best Practices & Trends BioPharma Life Sciences Other Topics Webinars
M&A Outlook 2019 This webinar discussion is focused around best practices in due diligence, potential red flags to avoid, and how working with an experienced team of trusted advisors paired with the right tools can help accelerate the discovery process. Best Practices & Trends Due Diligence Finance Mergers & Acquisitions Webinars
Demystifying Tech M&A Valuation This webinar explores the nuances of valuation, its framework, and the processes for getting it right in the mergers and acquisitions process. Finance Mergers & Acquisitions Other Topics Valuation Webinars